Pharma Stocks

Companies

Zydus to acquire US cancer drug company Assertio for $166.4 million in all-cash deal

The deal is the latest in a string of overseas acquisitions by the Ahmedabad drugmaker as it looks to diversify and strengthen its specialty plays in regulated markets.

2 min read13 May 2026
Markets

Three pharma stocks where FIIs raised stake in the March quarter

Pharma stocks have been attracting FIIs. Here are three stocks where FIIs have hiked stake in the March 2026 quarter.

4 min read9 May 2026
Markets

Wockhardt shares surge over 12% to 9-month high as company swings to profit in Q4

Wockhardt's shares surged 12.55% to ₹1,604 following a profitable Q4FY26 with a net profit of ₹164 crore. Strong revenue growth from biotech and emerging markets fueled performance, with full-year revenue rising to ₹3,373 crore and EBITDA increasing by 51%.

2 min read5 May 2026
Markets

Raja Venkatraman, MarketSmith recommend five stocks for 24 April

The Indian stock market experienced a downturn on April 24, as Nifty 50 and BSE Sensex declined amid rising crude oil prices and geopolitical uncertainties. Analysts suggest a flat market opening, recommending shares such as Praj Industries and Mankind Pharma for investors looking to buy.

5 min read24 Apr 2026
Markets

Lupin shares to be in focus on Thursday as USFDA approves Dapagliflozin and Metformin tablets

Lupin's shares are expected to attract investor attention as the company received U.S. FDA approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets.

1 min read8 Apr 2026
Industry

Boost for generics as Delhi HC says expired patents can still be cancelled

The ruling allows generic drugmakers to challenge the original legality of expired patents, potentially shielding them from past damage claims and speeding up the arrival of affordable medicines.

5 min read25 Feb 2026
Markets

Small-cap pharma stock jumps 2% from today's low. Do you own?

Small-cap stock Sudarshan Pharma has received vital certifications for its manufacturing facility, strengthening its commitment to quality and compliance. The stock trades in the green in the near term.

2 min read19 Feb 2026
Markets

Five CDMO stocks to add to your watchlist

Here are a list of 5 CDMO stocks that you can add to your watchlist as the industry continues to see good growth.

9 min read11 Feb 2026
Markets

₹15 to ₹2282: Multibagger stock turns ₹1 lakh into ₹1.52 crore in 15 years

NGL Fine Chem, a key player in pharmaceutical products, has seen its share price surge from ₹15 to ₹2,282, delivering multibagger gains to its investors.

2 min read9 Feb 2026
Markets

Small-cap pharma stock rebounds from today's low after this API update worth ₹250 crore

Sigachi Industries shares rebounded after announcing progress on a new combination of APIs for Cystic Fibrosis, projecting revenue of ₹250 cr annually by FY2026-27. The move enhances growth potential in a market expected to exceed USD 10 bln, focusing on innovative treatments for rare diseases.

1 min read21 Jan 2026